Arbutus Biopharma Corp - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 13, 2015

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Arbutus Biopharma Corpexh_322.htm
EX-32.1 - EXHIBIT 32.1 - Arbutus Biopharma Corpexh_321.htm
EX-23.1 - EXHIBIT 23.1 - Arbutus Biopharma Corpexh_231.htm
EX-31.2 - EXHIBIT 31.2 - Arbutus Biopharma Corpexh_312.htm
EX-10.51 - EXHIBIT 10.51 - Arbutus Biopharma Corpexh_1051.htm
EX-10.50 - EXHIBIT 10.50 - Arbutus Biopharma Corpexh_1050.htm
EX-10.53 - EXHIBIT 10.53 - Arbutus Biopharma Corpexh_1053.htm
EX-10.54 - EXHIBIT 10.54 - Arbutus Biopharma Corpexh_1054.htm
EX-10.59 - EXHIBIT 10.59 - Arbutus Biopharma Corpexh_1059.htm
EX-10.44 - EXHIBIT 10.44 - Arbutus Biopharma Corpexh_1044.htm
EX-10.64 - EXHIBIT 10.64 - Arbutus Biopharma Corpexh_1064.htm
EX-10.73 - EXHIBIT 10.73 - Arbutus Biopharma Corpexh_1073.htm
EX-10.66 - EXHIBIT 10.66 - Arbutus Biopharma Corpexh_1066.htm
EX-10.65 - EXHIBIT 10.65 - Arbutus Biopharma Corpexh_1065.htm
EX-10.41 - EXHIBIT 10.41 - Arbutus Biopharma Corpexh_1041.htm
EX-10.70 - EXHIBIT 10.70 - Arbutus Biopharma Corpexh_1070.htm
EX-10.69 - EXHIBIT 10.69 - Arbutus Biopharma Corpexh_1069.htm
EX-10.47 - EXHIBIT 10.47 - Arbutus Biopharma Corpexh_1047.htm
EX-10.75 - EXHIBIT 10.75 - Arbutus Biopharma Corpexh_1075.htm
EX-10.40 - EXHIBIT 10.40 - Arbutus Biopharma Corpexh_1040.htm
EX-10.49 - EXHIBIT 10.49 - Arbutus Biopharma Corpexh_1049.htm
EX-10.71 - EXHIBIT 10.71 - Arbutus Biopharma Corpexh_1071.htm
EX-10.56 - EXHIBIT 10.56 - Arbutus Biopharma Corpexh_1056.htm
EX-10.76 - EXHIBIT 10.76 - Arbutus Biopharma Corpexh_1076.htm
EX-10.67 - EXHIBIT 10.67 - Arbutus Biopharma Corpexh_1067.htm
EX-10.52 - EXHIBIT 10.52 - Arbutus Biopharma Corpexh_1052.htm
EX-10.58 - EXHIBIT 10.58 - Arbutus Biopharma Corpexh_1058.htm
EX-10.62 - EXHIBIT 10.62 - Arbutus Biopharma Corpexh_1062.htm
EX-10.61 - EXHIBIT 10.61 - Arbutus Biopharma Corpexh_1061.htm
EX-10.63 - EXHIBIT 10.63 - Arbutus Biopharma Corpexh_1063.htm
EX-10.74 - EXHIBIT 10.74 - Arbutus Biopharma Corpexh_1074.htm
EX-10.77 - EXHIBIT 10.77 - Arbutus Biopharma Corpexh_1077.htm
EX-10.60 - EXHIBIT 10.60 - Arbutus Biopharma Corpexh_1060.htm
EX-10.45 - EXHIBIT 10.45 - Arbutus Biopharma Corpexh_1045.htm
EX-10.72 - EXHIBIT 10.72 - Arbutus Biopharma Corpexh_1072.htm
EX-10.55 - EXHIBIT 10.55 - Arbutus Biopharma Corpexh_1055.htm
EX-10.43 - EXHIBIT 10.43 - Arbutus Biopharma Corpexh_1043.htm
EX-10.39 - EXHIBIT 10.39 - Arbutus Biopharma Corpexh_1039.htm
EX-10.42 - EXHIBIT 10.42 - Arbutus Biopharma Corpexh_1042.htm
EX-10.46 - EXHIBIT 10.46 - Arbutus Biopharma Corpexh_1046.htm
EX-10.48 - EXHIBIT 10.48 - Arbutus Biopharma Corpexh_1048.htm
EX-10.57 - EXHIBIT 10.57 - Arbutus Biopharma Corpexh_1057.htm
EXCEL - IDEA: XBRL DOCUMENT - Arbutus Biopharma CorpFinancial_Report.xls
10-K - FORM 10-K - Arbutus Biopharma Corpf10k_031215.htm
EX-31.1 - EXHIBIT 31.1 - Arbutus Biopharma Corpexh_311.htm
EX-10.68 - EXHIBIT 10.68 - Arbutus Biopharma Corpexh_1068.htm
Exhibit 21.1

 
Tekmira Pharmaceuticals Corporation
 
List of Subsidiaries
 
Name
Date on which the entity
became Tekmira’s wholly
owned sub
Jurisdiction
Protiva Biotherapeutics Inc.
May 30, 2008
British Columbia, Canada
Protiva Biotherapeutics (USA), Inc.
May 30, 2008
Delaware, United States of America
Protiva Agricultural Development Company Inc.
Jan. 9, 2014
British Columbia, Canada
OnCore Biopharma, Inc.
Mar. 4, 2015
Delaware, United States of America
Enantigen Therapeutics, Inc.
Mar. 4, 2015
Delaware, United States of America

Stock widget

Investing forum

Arbutus Biopharma Corp Reports